PTCT
PTC Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$69.30
−2.94%Leverage
- Debt / equity
- -4.21x
- Net debt / equity
- 2.14x
- Debt / assets
- 0.21x
- Debt / EBITDA
- 4.01x
- Net debt / EBITDA
- -2.04x
Liquidity & coverage
- Current ratio
- 3.39x
- Quick ratio
- 3.28x
- Cash ratio
- 2.89x
- Interest coverage
- 0.63x
- EBITDA / interest
- 0.94x
- Working capital
- $1.8B
Cash & dividend
- FCF / debt
- -0.48x
- Cash flow / debt
- -0.04x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026